Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$7.04 - $11.7 $176,000 - $292,500
-25,000 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$9.98 - $18.04 $241,516 - $436,568
-24,200 Reduced 49.19%
25,000 $267,000
Q2 2020

Aug 14, 2020

BUY
$7.49 - $15.16 $85,386 - $172,824
11,400 Added 30.16%
49,200 $746,000
Q1 2020

May 15, 2020

SELL
$4.62 - $18.74 $178,332 - $723,363
-38,600 Reduced 50.52%
37,800 $315,000
Q4 2019

Feb 14, 2020

BUY
$14.6 - $18.13 $524,140 - $650,867
35,900 Added 88.64%
76,400 $1.29 Million
Q3 2019

Nov 14, 2019

BUY
$16.62 - $23.92 $673,110 - $968,760
40,500 New
40,500 $752,000
Q2 2019

Aug 14, 2019

SELL
$17.79 - $22.88 $1.24 Million - $1.6 Million
-69,800 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$10.42 - $21.94 $727,316 - $1.53 Million
69,800 New
69,800 $803,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.